BFLY Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Revenue Growth And GuidanceRapid revenue growth and higher full-year guidance indicate strengthening demand and improving execution across the business. If sustained, this expanding revenue base can support operating leverage, fund product investment, and improve Butterfly’s ability to scale its point-of-care ultrasound platform.
Improving Gross Margin And EBITDAThe sharp improvement in adjusted gross margin and EBITDA performance suggests better product economics and progress toward a more scalable cost structure. Continued margin conversion would reduce the funding burden of growth and increase the likelihood of reaching management’s longer-term profitability objectives.
Enterprise Software And Platform ExpansionEnterprise wins and multi-year Compass AI contracts can create a more recurring revenue mix while embedding Butterfly in health-system workflows. The platform also accepts scans from competing devices, potentially broadening software reach and creating a durable path to later hardware adoption.
Bears Say
Deep Ongoing UnprofitabilityButterfly remains deeply unprofitable relative to its current revenue base, showing that operating costs have not yet scaled sufficiently. Persistent losses constrain internal reinvestment, increase reliance on financing or cash reserves, and leave execution on the growth plan central to shareholder outcomes.
Continued Cash BurnNegative operating and free cash flow means the company is still consuming cash to operate and grow, rather than funding expansion internally. Deteriorating free cash flow increases the importance of achieving planned efficiency gains and raises the risk that prolonged losses could require additional capital.
Uneven Embedded Revenue TimingThe Embedded opportunity is strategically attractive but its revenue recognition is inherently uneven, making quarterly results and near-term planning less predictable. Dependence on partner milestones and contract conversion can delay expected growth, complicate resource allocation, and prolong the path to consistent profitability.
Butterfly Network News
BFLY FAQ
What was Butterfly Network’s price range in the past 12 months?
Currently, no data Available
What is Butterfly Network’s market cap?
Butterfly Network’s market cap is $31.97B.
When is Butterfly Network’s upcoming earnings report date?
Butterfly Network’s upcoming earnings report date is Mar 03, 2027 which is in 122 days.
How were Butterfly Network’s earnings last quarter?
Butterfly Network released its earnings results on Oct 29, 2026. The company reported -$0.188 earnings per share for the quarter, beating the consensus estimate of -$0.658 by $0.47.
Is Butterfly Network overvalued?
According to Wall Street analysts Butterfly Network’s price is currently Undervalued.
Does Butterfly Network pay dividends?
Butterfly Network does not currently pay dividends.
What is Butterfly Network’s EPS estimate?
Butterfly Network’s EPS estimate is -0.38.
How many shares outstanding does Butterfly Network have?
Butterfly Network has 244,858,250 shares outstanding.
What happened to Butterfly Network’s price movement after its last earnings report?
Butterfly Network reported an EPS of -$0.188 in its last earnings report, beating expectations of -$0.658. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Butterfly Network?
Currently, no hedge funds are holding shares in MX:BFLY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Butterfly Network Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$206.65 (― Upside)
$206.65 (― Upside)
Blogger Sentiment
Bullish
MX:BFLY Sentiment 78%
Sector Average 64%
Sector Average 64%
Insider Transactions
Sold Shares
Worth $654.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 80%
Bearish news 20%
Bearish news 20%
Technicals
SMA
Positive
20 days / 200 days
Momentum
213.23%
12-Months-Change
Fundamentals
Return on Equity
-28.22%
Trailing 12-Months
Asset Growth
-0.70%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Butterfly Network
Butterfly Network, Inc. functions as a digital health enterprise, specializing in the invention, production, and global commercialization of cutting-edge ultrasound imaging technologies for both domestic and international markets. The company's innovative product portfolio includes the portable Butterfly iQ, a versatile single-probe system capable of whole-body ultrasound imaging, and the Butterfly iQ+, a point-of-care ultrasound device engineered to connect effortlessly with smartphones, tablets, and existing hospital computer networks. Additionally, Butterfly Blueprint is offered as a comprehensive, system-wide ultrasound platform that seamlessly integrates its proprietary Compass software into a healthcare provider's clinical and administrative infrastructure. These ultrasound systems, encompassing probes, related accessories, and software subscriptions, are supplied to healthcare systems, individual physicians, and other medical professionals through a multi-channel distribution strategy that includes a direct sales force, a network of distributors, and an e-commerce platform. Beyond its hardware, Butterfly Network provides a suite of cloud-based software solutions for healthcare organizations. These offerings feature teleguidance services, interactive in-app educational modules, and structured training programs delivered via its Butterfly Academy software, all complemented by dedicated clinical support and services. Established in 2011, Butterfly Network, Inc. has its corporate headquarters situated in Guilford, Connecticut.
BFLY Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was strongly positive. The company reported 52% year-over-year revenue growth, record gross margin, an 85% improvement in Adjusted EBITDA loss, major Embedded revenue growth, strong U.S. enterprise traction, and higher full-year guidance. The main challenges were a 5% international revenue decline, a 9% decline in iQ+ sales, continued Adjusted EBITDA losses, uneven Embedded revenue timing, and ongoing macroeconomic pressures. Management remained confident in the 2027 product, international, Embedded, and Home & Community Care opportunities.View all MX:BFLY earnings summariesBFLY Stock 12 Month Forecast
Average Price Target
―Koninklijke Philips
―
Nano-X Imaging
―
Hyperfine
―
QT Imaging Holdings
―
GE Healthcare Technologies Inc
―